Article 11 — Risk-mitigation techniques for OTC derivative contracts not cleared by a CCP
Showing 50 of 50Release 10 Nov 2026Details
- Coverage
- Not covered: national guidance, court decisions.
- Freshness
- Release 2d86bd12 published 10 Nov 2026, 17:06 CET.
- Shown
- Showing 50 of 50
- Failures
- None.
- Incomplete
- No.
Implemented by · Level 24
149/2013RTS — Indirect clearing, clearing obligation, public register [in force]285/2014RTS — Direct, substantial and foreseeable effect of contracts [in force]2016/2251RTS — Risk-mitigation techniques for OTC derivative contracts [in force]2026/1000Delegated act — Fees charged for the validation of pro forma models [in force]
Explained by · Level 34
Cited by11
4(2)Clearing obligation4b(1)Post-trade risk reduction services13(1)Mechanism to avoid duplicative or conflicting rules with regard to OTC derivative contracts not cleared by a CCP13(2)(a)Mechanism to avoid duplicative or conflicting rules with regard to OTC derivative contracts not cleared by a CCP13(3)Mechanism to avoid duplicative or conflicting rules with regard to OTC derivative contracts not cleared by a CCP13a(1)Amendments to legacy contracts for the purpose of the implementation of benchmark reforms82(2)Exercise of the delegation82(3)Exercise of the delegation82(6)Exercise of the delegation89(1)Transitional provisions89(13)Transitional provisions
Defined terms0
None linked in our corpus.
Amended by2
17 Jan 202532022R255424 Dec 202432024R2987